HeartBeam Inc has a consensus price target of $6.78, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Benchmark, and Benchmark on March 25, 2024, November 16, 2023, and August 24, 2023. With an average price target of $8 between Benchmark, Benchmark, and Benchmark, there's an implied 247.83% upside for HeartBeam Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/25/2024 | BEAT | Buy Now | HeartBeam | $2.30 | 247.83% | Benchmark | Bill Sutherland | → $8 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
11/16/2023 | BEAT | Buy Now | HeartBeam | $2.30 | 247.83% | Benchmark | Bill Sutherland | → $8 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
08/24/2023 | BEAT | Buy Now | HeartBeam | $2.30 | 247.83% | Benchmark | Bill Sutherland | → $8 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
05/19/2023 | BEAT | Buy Now | HeartBeam | $2.30 | 141.3% | Alliance Global Partners | Ben Haynor | $10 → $5.55 | Maintains | Buy | Get Alert |
05/19/2023 | BEAT | Buy Now | HeartBeam | $2.30 | 247.83% | Benchmark | Bill Sutherland | → $8 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
03/21/2023 | BEAT | Buy Now | HeartBeam | $2.30 | 247.83% | Benchmark | Bill Sutherland | → $8 | Reiterates | → Speculative Buy | Get Alert |
12/02/2022 | BEAT | Buy Now | HeartBeam | $2.30 | 334.78% | Alliance Global Partners | Ben Haynor | → $10 | Initiates | → Buy | Get Alert |
12/20/2021 | BEAT | Buy Now | BioTelemetry | $2.30 | 291.3% | Benchmark | Bill Sutherland | — | Initiates | → Speculative Buy | Get Alert |
The latest price target for HeartBeam (NASDAQ: BEAT) was reported by Benchmark on March 25, 2024. The analyst firm set a price target for $8.00 expecting BEAT to rise to within 12 months (a possible 247.83% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for HeartBeam (NASDAQ: BEAT) was provided by Benchmark, and HeartBeam reiterated their speculative buy rating.
There is no last upgrade for HeartBeam.
There is no last downgrade for HeartBeam.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HeartBeam, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HeartBeam was filed on March 25, 2024 so you should expect the next rating to be made available sometime around March 25, 2025.
While ratings are subjective and will change, the latest HeartBeam (BEAT) rating was a reiterated with a price target of $0.00 to $8.00. The current price HeartBeam (BEAT) is trading at is $2.30, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.